NUMIF NUMINUS WELLNESS INC
- 0.027900
- +0.003800+15.77%
NUMINUS WELLNESS INC News
Numinus Wellness Sells US Clinics, Partners With Stella For Tech-Driven Mental Health Solutions
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Earnings Call Summary | NUMINUS WELLNESS INC(NUMIF.US) Q3 2024 Earnings Conference
Numinus Wellness Reports Q3 Results
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024
MedBright AI Announces Strategic Acquisition by Numinus Wellness
Psychedelic Stocks Fall as FDA Panel Rejects MDMA Therapy
Psychedelic Stocks Mixed as FDA Comments on MDMA Therapy
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder
Numinus Wellness Secures Health Canada Approval for Study Into Group Model For MDMA-Assisted Therapy
Earnings Call Summary | NUMINUS WELLNESS INC(NUMIF.US) Q2 2024 Earnings Conference
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
Numinus Wellness Shares Down on Canadian Operations Reorganization
Numinus Wellness Reports Q2 Results
Numinus Wellness Q2 Earnings Preview
Press Release: Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results
Earnings Preview: NUMIF to Report Financial Results on April 15
$NUMINUS WELLNESS INC(NUMIF.US)$ is scheduled to release its financial results on April 15. Earnings PreviewAnalysts estimate $NUMINUS WELLNESS INC(NUMIF.US)$ to post revenue of CAD6.46 million for 20
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
PharmAla Biotech Signs Sale Agreement With Numinus Wellness
No Data